Skip to main content
Top
Published in: Current Cardiology Reports 6/2016

01-06-2016 | Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)

The Role of Healthy Lifestyle in the Primordial Prevention of Cardiovascular Disease

Authors: Steven A. Claas, Donna K. Arnett

Published in: Current Cardiology Reports | Issue 6/2016

Login to get access

Abstract

Whereas primary prevention seeks to forestall development of disease in individuals with elevated risk, primordial prevention seeks to preempt the development of risk factors. Health behaviors—characterized as “lifestyle” factors—are key interventional targets in primordial prevention of cardiovascular disease. Appropriate dietary intake, including limiting salt and saturated fat consumption, can reduce the risk of developing hypertension and dyslipidemias. Regular physical activity is associated with lower blood pressure and healthier lipid profiles. Diet and exercise are critical to maintaining weight conducive to cardiovascular health. Behavioral factors such as stress management, sleep duration, portion control, and meal timing may play a role in weight management and offer additional routes of intervention. Any smoking elevates cardiovascular risk. Although lifestyle modification programs can be instrumental in reaching public health goals, maintaining cardiovascular health should not be a matter solely of willpower. Ideally, structural and social forces should make healthy lifestyles the default option.
Literature
1.•
go back to reference Mozaffarian D, Benjamin EJ, Go AS, et al.: Heart Disease and Stroke Statistics-2016 update: a report from the American Heart Association. Circulation. 2015. The latest of the AHA’s yearly and definitive assessments of the state of CV health and disease in the US. Mozaffarian D, Benjamin EJ, Go AS, et al.: Heart Disease and Stroke Statistics-2016 update: a report from the American Heart Association. Circulation. 2015. The latest of the AHA’s yearly and definitive assessments of the state of CV health and disease in the US.
2.
go back to reference Labarthe DR. From cardiovascular disease to cardiovascular health: a quiet revolution? Circ Cardiovasc Qual Outcomes. 2012;5:e86–92.CrossRefPubMed Labarthe DR. From cardiovascular disease to cardiovascular health: a quiet revolution? Circ Cardiovasc Qual Outcomes. 2012;5:e86–92.CrossRefPubMed
3.
go back to reference Strasser T. Reflections on cardiovascular diseases. Interdiscip Sci Rev. 1978;3:225–30.CrossRef Strasser T. Reflections on cardiovascular diseases. Interdiscip Sci Rev. 1978;3:225–30.CrossRef
4.
go back to reference National Heart LaBI. Report of the task force on research in epidemiology and prevention of cardiovascular diseases. Washington, DC: National Institutes of Health, Public Health Service, US Department of Health and Human Services; 1994. National Heart LaBI. Report of the task force on research in epidemiology and prevention of cardiovascular diseases. Washington, DC: National Institutes of Health, Public Health Service, US Department of Health and Human Services; 1994.
7.
go back to reference Weintraub WS, Daniels SR, Burke LE, et al. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation. 2011;124:967–90.CrossRefPubMed Weintraub WS, Daniels SR, Burke LE, et al. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation. 2011;124:967–90.CrossRefPubMed
8.
go back to reference Appleton AA, Buka SL, Loucks EB, et al. A prospective study of positive early-life psychosocial factors and favorable cardiovascular risk in adulthood. Circulation. 2013;127:905–12.CrossRefPubMedPubMedCentral Appleton AA, Buka SL, Loucks EB, et al. A prospective study of positive early-life psychosocial factors and favorable cardiovascular risk in adulthood. Circulation. 2013;127:905–12.CrossRefPubMedPubMedCentral
10.
go back to reference Mozaffarian D, Fahimi S, Singh GM, et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med. 2014;371:624–34.CrossRefPubMed Mozaffarian D, Fahimi S, Singh GM, et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med. 2014;371:624–34.CrossRefPubMed
11.
go back to reference Alderman MH, Cohen HW. Dietary sodium intake and cardiovascular mortality: controversy resolved? Am J Hypertens. 2012;25:727–34.CrossRefPubMed Alderman MH, Cohen HW. Dietary sodium intake and cardiovascular mortality: controversy resolved? Am J Hypertens. 2012;25:727–34.CrossRefPubMed
13.
go back to reference Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121:586–613.CrossRefPubMed Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121:586–613.CrossRefPubMed
14.
go back to reference Appel LJ, Baker DH, Bar-Or O, et al. Dietary reference intakes for water, potassium, sodium, chloride, and sulfate. Washington, DC: Institute of Medicine; 2005. Appel LJ, Baker DH, Bar-Or O, et al. Dietary reference intakes for water, potassium, sodium, chloride, and sulfate. Washington, DC: Institute of Medicine; 2005.
15.
go back to reference Ekmekcioglu C, Elmadfa I, Meyer AL et al. The role of dietary potassium in hypertension and diabetes. J Physiol Biochem. 2015. Ekmekcioglu C, Elmadfa I, Meyer AL et al. The role of dietary potassium in hypertension and diabetes. J Physiol Biochem. 2015.
16.
go back to reference Binia A, Jaeger J, Hu Y, et al. Daily potassium intake and sodium-to-potassium ratio in the reduction of blood pressure: a meta-analysis of randomized controlled trials. J Hypertens. 2015;33:1509–20.CrossRefPubMed Binia A, Jaeger J, Hu Y, et al. Daily potassium intake and sodium-to-potassium ratio in the reduction of blood pressure: a meta-analysis of randomized controlled trials. J Hypertens. 2015;33:1509–20.CrossRefPubMed
17.
go back to reference Aaron KJ, Sanders PW. Role of dietary salt and potassium intake in cardiovascular health and disease: a review of the evidence. Mayo Clin Proc. 2013;88:987–95.CrossRefPubMed Aaron KJ, Sanders PW. Role of dietary salt and potassium intake in cardiovascular health and disease: a review of the evidence. Mayo Clin Proc. 2013;88:987–95.CrossRefPubMed
18.
go back to reference Kodavali L, Townsend RR. Alcohol and its relationship to blood pressure. Curr Hypertens Rep. 2006;8:338–44.CrossRefPubMed Kodavali L, Townsend RR. Alcohol and its relationship to blood pressure. Curr Hypertens Rep. 2006;8:338–44.CrossRefPubMed
19.
go back to reference Klatsky AL. Alcohol and cardiovascular diseases: where do we stand today? J Intern Med. 2015;278:238–50.CrossRefPubMed Klatsky AL. Alcohol and cardiovascular diseases: where do we stand today? J Intern Med. 2015;278:238–50.CrossRefPubMed
20.
go back to reference 2015-2020 dietary guidelines for Americans. US Department of Health and Human Services and US Department of Agriculture. 2015. 2015-2020 dietary guidelines for Americans. US Department of Health and Human Services and US Department of Agriculture. 2015.
21.
go back to reference Obarzanek E, Sacks FM, Vollmer WM, et al. Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Clin Nutr. 2001;74:80–9.PubMed Obarzanek E, Sacks FM, Vollmer WM, et al. Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Clin Nutr. 2001;74:80–9.PubMed
22.
go back to reference Ginsberg HN, Kris-Etherton P, Dennis B, et al. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. Arterioscler, Thromb, Vasc Biol. 1998;18:441–9.CrossRef Ginsberg HN, Kris-Etherton P, Dennis B, et al. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. Arterioscler, Thromb, Vasc Biol. 1998;18:441–9.CrossRef
23.
go back to reference Berglund L, Lefevre M, Ginsberg HN, et al. Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. Am J Clin Nutr. 2007;86:1611–20.PubMed Berglund L, Lefevre M, Ginsberg HN, et al. Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. Am J Clin Nutr. 2007;86:1611–20.PubMed
24.
go back to reference Mensink RP, Zock PL, Kester AD, et al. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;77:1146–55.PubMed Mensink RP, Zock PL, Kester AD, et al. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;77:1146–55.PubMed
25.
go back to reference Mozaffarian D, Clarke R. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr. 2009;63 Suppl 2:S22–33.CrossRefPubMed Mozaffarian D, Clarke R. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr. 2009;63 Suppl 2:S22–33.CrossRefPubMed
26.
go back to reference Magnussen CG, Niinikoski H, Juonala M, et al. When and how to start prevention of atherosclerosis? Lessons from the Cardiovascular Risk in the Young Finns Study and the Special Turku Coronary Risk Factor Intervention Project. Pediatr Nephrol. 2012;27:1441–52.CrossRefPubMed Magnussen CG, Niinikoski H, Juonala M, et al. When and how to start prevention of atherosclerosis? Lessons from the Cardiovascular Risk in the Young Finns Study and the Special Turku Coronary Risk Factor Intervention Project. Pediatr Nephrol. 2012;27:1441–52.CrossRefPubMed
27.
go back to reference Niinikoski H, Pahkala K, Ala-Korpela M, et al. Effect of repeated dietary counseling on serum lipoproteins from infancy to adulthood. Pediatrics. 2012;129:e704–13.CrossRefPubMed Niinikoski H, Pahkala K, Ala-Korpela M, et al. Effect of repeated dietary counseling on serum lipoproteins from infancy to adulthood. Pediatrics. 2012;129:e704–13.CrossRefPubMed
28.
go back to reference Yang Q, Zhang Z, Gregg EW, et al. Added sugar intake and cardiovascular diseases mortality among US adults. JAMA internal medicine. 2014;174:516–24.CrossRefPubMed Yang Q, Zhang Z, Gregg EW, et al. Added sugar intake and cardiovascular diseases mortality among US adults. JAMA internal medicine. 2014;174:516–24.CrossRefPubMed
29.
go back to reference Dhurandhar NV, Thomas D. The link between dietary sugar intake and cardiovascular disease mortality: an unresolved question. Jama. 2015;313:959–60.CrossRefPubMed Dhurandhar NV, Thomas D. The link between dietary sugar intake and cardiovascular disease mortality: an unresolved question. Jama. 2015;313:959–60.CrossRefPubMed
31.
go back to reference Brown IJ, Stamler J, Van Horn L, et al. Sugar-sweetened beverage, sugar intake of individuals, and their blood pressure: international study of macro/micronutrients and blood pressure. Hypertension. 2011;57:695–701.CrossRefPubMedPubMedCentral Brown IJ, Stamler J, Van Horn L, et al. Sugar-sweetened beverage, sugar intake of individuals, and their blood pressure: international study of macro/micronutrients and blood pressure. Hypertension. 2011;57:695–701.CrossRefPubMedPubMedCentral
32.
go back to reference Malik AH, Akram Y, Shetty S, et al. Impact of sugar-sweetened beverages on blood pressure. Am J Cardiol. 2014;113:1574–80.CrossRefPubMed Malik AH, Akram Y, Shetty S, et al. Impact of sugar-sweetened beverages on blood pressure. Am J Cardiol. 2014;113:1574–80.CrossRefPubMed
33.
go back to reference Jayalath VH, de Souza RJ, Ha V, et al. Sugar-sweetened beverage consumption and incident hypertension: a systematic review and meta-analysis of prospective cohorts. Am J Clin Nutr. 2015;102:914–21.CrossRefPubMed Jayalath VH, de Souza RJ, Ha V, et al. Sugar-sweetened beverage consumption and incident hypertension: a systematic review and meta-analysis of prospective cohorts. Am J Clin Nutr. 2015;102:914–21.CrossRefPubMed
34.
go back to reference Stanhope KL, Medici V, Bremer AA, et al. A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults. Am J Clin Nutr. 2015;101:1144–54.CrossRefPubMed Stanhope KL, Medici V, Bremer AA, et al. A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults. Am J Clin Nutr. 2015;101:1144–54.CrossRefPubMed
35.
go back to reference Raben A, Moller BK, Flint A et al. Increased postprandial glycaemia, insulinemia, and lipidemia after 10 weeks’ sucrose-rich diet compared to an artificially sweetened diet: a randomised controlled trial. Food Nutr Res. 2011; 55. Raben A, Moller BK, Flint A et al. Increased postprandial glycaemia, insulinemia, and lipidemia after 10 weeks’ sucrose-rich diet compared to an artificially sweetened diet: a randomised controlled trial. Food Nutr Res. 2011; 55.
37.
go back to reference Karanja NM, Obarzanek E, Lin PH, et al. Descriptive characteristics of the dietary patterns used in the Dietary Approaches to Stop Hypertension Trial. DASH Collaborative Research Group. J Am Diet Assoc. 1999;99:S19–27.CrossRefPubMed Karanja NM, Obarzanek E, Lin PH, et al. Descriptive characteristics of the dietary patterns used in the Dietary Approaches to Stop Hypertension Trial. DASH Collaborative Research Group. J Am Diet Assoc. 1999;99:S19–27.CrossRefPubMed
39.
go back to reference Whelton SP, Chin A, Xin X, et al. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2002;136:493–503.CrossRefPubMed Whelton SP, Chin A, Xin X, et al. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2002;136:493–503.CrossRefPubMed
40.••
go back to reference Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S76–99. This documents the AHA’s assessment of all lifestyle-based primordial and primary prevention interventions and the level of evidence associated with each. The 172-page full report is available online.CrossRefPubMed Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S76–99. This documents the AHA’s assessment of all lifestyle-based primordial and primary prevention interventions and the level of evidence associated with each. The 172-page full report is available online.CrossRefPubMed
41.
go back to reference Sousa N, Mendes R, Abrantes C, et al. A randomized 9-month study of blood pressure and body fat responses to aerobic training versus combined aerobic and resistance training in older men. Exp Gerontol. 2013;48:727–33.CrossRefPubMed Sousa N, Mendes R, Abrantes C, et al. A randomized 9-month study of blood pressure and body fat responses to aerobic training versus combined aerobic and resistance training in older men. Exp Gerontol. 2013;48:727–33.CrossRefPubMed
42.
go back to reference Kelley GA, Kelley KS, Tran ZV. Walking, lipids, and lipoproteins: a meta-analysis of randomized controlled trials. Prev Med. 2004;38:651–61.CrossRefPubMed Kelley GA, Kelley KS, Tran ZV. Walking, lipids, and lipoproteins: a meta-analysis of randomized controlled trials. Prev Med. 2004;38:651–61.CrossRefPubMed
43.
go back to reference Kelley GA, Kelley KS, Tran ZV. Aerobic exercise and lipids and lipoproteins in women: a meta-analysis of randomized controlled trials. J Womens Health (Larchmt). 2004;13:1148–64.CrossRef Kelley GA, Kelley KS, Tran ZV. Aerobic exercise and lipids and lipoproteins in women: a meta-analysis of randomized controlled trials. J Womens Health (Larchmt). 2004;13:1148–64.CrossRef
45.
go back to reference Kodama S, Tanaka S, Saito K, et al. Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. Arch Intern Med. 2007;167:999–1008.CrossRefPubMed Kodama S, Tanaka S, Saito K, et al. Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. Arch Intern Med. 2007;167:999–1008.CrossRefPubMed
46.
go back to reference Committee PAGA. Physical activity guidelines advisory committee report, 2008. Washington, DC: US Department of Health and Human Services; 2008. Committee PAGA. Physical activity guidelines advisory committee report, 2008. Washington, DC: US Department of Health and Human Services; 2008.
47.
go back to reference Kelley GA, Kelley KS. Impact of progressive resistance training on lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials. Prev Med. 2009;48:9–19.CrossRefPubMed Kelley GA, Kelley KS. Impact of progressive resistance training on lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials. Prev Med. 2009;48:9–19.CrossRefPubMed
48.
go back to reference Kelley GA, Kelley KS. Impact of progressive resistance training on lipids and lipoproteins in adults: another look at a meta-analysis using prediction intervals. Prev Med. 2009;49:473–5.CrossRefPubMed Kelley GA, Kelley KS. Impact of progressive resistance training on lipids and lipoproteins in adults: another look at a meta-analysis using prediction intervals. Prev Med. 2009;49:473–5.CrossRefPubMed
49.
go back to reference Epel E, Lapidus R, McEwen B, et al. Stress may add bite to appetite in women: a laboratory study of stress-induced cortisol and eating behavior. Psychoneuroendocrinology. 2001;26:37–49.CrossRefPubMed Epel E, Lapidus R, McEwen B, et al. Stress may add bite to appetite in women: a laboratory study of stress-induced cortisol and eating behavior. Psychoneuroendocrinology. 2001;26:37–49.CrossRefPubMed
50.
go back to reference Rutters F, Nieuwenhuizen AG, Lemmens SG, et al. Acute stress-related changes in eating in the absence of hunger. Obesity (Silver Spring). 2009;17:72–7.CrossRef Rutters F, Nieuwenhuizen AG, Lemmens SG, et al. Acute stress-related changes in eating in the absence of hunger. Obesity (Silver Spring). 2009;17:72–7.CrossRef
51.
go back to reference Epel E, Jimenez S, Brownell K, et al. Are stress eaters at risk for the metabolic syndrome? Ann N Y Acad Sci. 2004;1032:208–10.CrossRefPubMed Epel E, Jimenez S, Brownell K, et al. Are stress eaters at risk for the metabolic syndrome? Ann N Y Acad Sci. 2004;1032:208–10.CrossRefPubMed
52.
go back to reference Patel SR, Hu FB. Short sleep duration and weight gain: a systematic review. Obesity (Silver Spring). 2008;16:643–53.CrossRef Patel SR, Hu FB. Short sleep duration and weight gain: a systematic review. Obesity (Silver Spring). 2008;16:643–53.CrossRef
55.
go back to reference Peter Herman C, Polivy J, Pliner P, et al. Mechanisms underlying the portion-size effect. Physiol Behav. 2015;144:129–36.CrossRefPubMed Peter Herman C, Polivy J, Pliner P, et al. Mechanisms underlying the portion-size effect. Physiol Behav. 2015;144:129–36.CrossRefPubMed
58.
go back to reference Lanza ST, Vasilenko SA. New methods shed light on age of onset as a risk factor for nicotine dependence. Addict Behav. 2015;50:161–4.CrossRefPubMed Lanza ST, Vasilenko SA. New methods shed light on age of onset as a risk factor for nicotine dependence. Addict Behav. 2015;50:161–4.CrossRefPubMed
59.
go back to reference Peirson L, Ali MU, Kenny M, et al. Interventions for prevention and treatment of tobacco smoking in school-aged children and adolescents: a systematic review and meta-analysis. Prev Med. 2015;85:20–31.CrossRefPubMed Peirson L, Ali MU, Kenny M, et al. Interventions for prevention and treatment of tobacco smoking in school-aged children and adolescents: a systematic review and meta-analysis. Prev Med. 2015;85:20–31.CrossRefPubMed
62.
go back to reference Yang Q, Cogswell ME, Flanders WD, et al. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. Jama. 2012;307:1273–83.CrossRefPubMed Yang Q, Cogswell ME, Flanders WD, et al. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. Jama. 2012;307:1273–83.CrossRefPubMed
63.
go back to reference Folsom AR, Yatsuya H, Nettleton JA, et al. Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol. 2011;57:1690–6.CrossRefPubMedPubMedCentral Folsom AR, Yatsuya H, Nettleton JA, et al. Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol. 2011;57:1690–6.CrossRefPubMedPubMedCentral
64.
go back to reference Kulshreshtha A, Vaccarino V, Judd SE, et al. Life’s Simple 7 and risk of incident stroke: the reasons for geographic and racial differences in stroke study. Stroke. 2013;44:1909–14.CrossRefPubMed Kulshreshtha A, Vaccarino V, Judd SE, et al. Life’s Simple 7 and risk of incident stroke: the reasons for geographic and racial differences in stroke study. Stroke. 2013;44:1909–14.CrossRefPubMed
65.
go back to reference Olson NC, Cushman M, Judd SE, et al. American Heart Association’s Life’s Simple 7 and risk of venous thromboembolism: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. J Am Heart Assoc. 2015;4:e001494.CrossRefPubMedPubMedCentral Olson NC, Cushman M, Judd SE, et al. American Heart Association’s Life’s Simple 7 and risk of venous thromboembolism: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. J Am Heart Assoc. 2015;4:e001494.CrossRefPubMedPubMedCentral
66.
go back to reference Thacker EL, Gillett SR, Wadley VG, et al. The American Heart Association Life’s Simple 7 and incident cognitive impairment: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study. J Am Heart Assoc. 2014;3:e000635.CrossRefPubMedPubMedCentral Thacker EL, Gillett SR, Wadley VG, et al. The American Heart Association Life’s Simple 7 and incident cognitive impairment: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study. J Am Heart Assoc. 2014;3:e000635.CrossRefPubMedPubMedCentral
67.
go back to reference Yang Q, Zhang B, Deng P, et al. Assessing cardiovascular health using Life’s Simple 7 in a Chinese population undergoing stroke prevention. Chin Med J (Engl). 2015;128:2450–6.CrossRef Yang Q, Zhang B, Deng P, et al. Assessing cardiovascular health using Life’s Simple 7 in a Chinese population undergoing stroke prevention. Chin Med J (Engl). 2015;128:2450–6.CrossRef
68.
go back to reference Fretts AM, Howard BV, McKnight B, et al. Life’s Simple 7 and incidence of diabetes among American Indians: the strong heart family study. Diabetes Care. 2014;37:2240–5.CrossRefPubMedPubMedCentral Fretts AM, Howard BV, McKnight B, et al. Life’s Simple 7 and incidence of diabetes among American Indians: the strong heart family study. Diabetes Care. 2014;37:2240–5.CrossRefPubMedPubMedCentral
69.
go back to reference Brown DL, Conley KM, Sanchez BN, et al. A multicomponent behavioral intervention to reduce stroke risk factor behaviors: the stroke health and risk education cluster-randomized controlled trial. Stroke. 2015;46:2861–7.CrossRefPubMed Brown DL, Conley KM, Sanchez BN, et al. A multicomponent behavioral intervention to reduce stroke risk factor behaviors: the stroke health and risk education cluster-randomized controlled trial. Stroke. 2015;46:2861–7.CrossRefPubMed
70.
go back to reference Shah A, Clayman ML, Glass S, et al. Protect your heart: a culture-specific multimedia cardiovascular health education program. J Health Commun. 2015;20:424–30.CrossRefPubMedPubMedCentral Shah A, Clayman ML, Glass S, et al. Protect your heart: a culture-specific multimedia cardiovascular health education program. J Health Commun. 2015;20:424–30.CrossRefPubMedPubMedCentral
71.••
go back to reference Pearson TA, Palaniappan LP, Artinian NT, et al. American Heart Association Guide for improving cardiovascular health at the community level, 2013 update: a scientific statement for public health practitioners, healthcare providers, and health policy makers. Circulation. 2013;127:1730–53. This describes the AHA’s rationales and recommendations for community-based primordial and primary prevention measures.CrossRefPubMed Pearson TA, Palaniappan LP, Artinian NT, et al. American Heart Association Guide for improving cardiovascular health at the community level, 2013 update: a scientific statement for public health practitioners, healthcare providers, and health policy makers. Circulation. 2013;127:1730–53. This describes the AHA’s rationales and recommendations for community-based primordial and primary prevention measures.CrossRefPubMed
Metadata
Title
The Role of Healthy Lifestyle in the Primordial Prevention of Cardiovascular Disease
Authors
Steven A. Claas
Donna K. Arnett
Publication date
01-06-2016
Publisher
Springer US
Published in
Current Cardiology Reports / Issue 6/2016
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-016-0728-7

Other articles of this Issue 6/2016

Current Cardiology Reports 6/2016 Go to the issue

Pericardial Disease (AL Klein, Section Editor)

Recurrent Pericarditis: Modern Approach in 2016

Cardiovascular Genomics (TL Assimes, Section Editor)

Genomics of Atrial Fibrillation